The role of heparanase in lymph node metastatic dissemination: Dynamic contrast-enhanced MRI of Eb lymphoma in mice

Neoplasia

Volumn 7, Issue 3, 2005, Pages 224-233

  Dafni, Hagit ^a   Cohen, Batya ^a   Ziv, Keren ^a   Israely, Tomer ^a   Goldshmidt, Orit ^b   Nevo, Nava ^a   Harmelin, Alon ^a   Vlodavsky, Israel ^c   Neeman, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Heparanase; Lymphangiography; Lymphatic drain; MRI; Vascular permeability

Indexed keywords

BIOTIN; GREEN FLUORESCENT PROTEIN; HEPARANASE;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; CANCER INVASION; CANCER STAGING; CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; EXTRACELLULAR MATRIX; EXTRAVASATION; LYMPH NODE METASTASIS; LYMPHANGIOGRAPHY; LYMPHOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T CELL LYMPHOMA;

EID: 15744378083     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04433     Document Type: Article

References (39)

1. Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, Peretz T, and Friedmann Y (2002). Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12, 121-129.
2. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, Schirrmacher V, Mitrani E, and Vlodavsky I (2002). Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 99, 10031-10036.
3. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, and Parish CR (1999). Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5, 803-809.
4. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, and Nicolson GL (1983). Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220, 611-613.
5. Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, and Pappo O (2000). Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 157, 1167-1175.
6. Papoutsi M, Siemeister G, Weindel K, Tomarev SI, Kurz H, Schachtele C, Martiny-Baron G, Christ B, Marme D, and Wilting J (2000). Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 114, 373-385.
7. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, and Alitalo K (2002). Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94, 819-825.
8. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa Si S, Kubo H, and Achen MG (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7, 186-191.
9. Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, and Aarsvold JN (2000). Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med 30, 56-64.
10. Shimada M, Yoshikawa K, Suganuma T, Kayanuma H, Inoue Y, Ito K, Senoo A, and Hayashi S (2003). Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine-pentaacetic acid. J Comput Assist Tomogr 27, 641-646.
11. Ruehm SG, Corot C, and Debatin JF (2001). Interstitial MR lymphography with a conventional extracellular gadolinium-based agent: assessment in rabbits. Radiology 218, 664-669.
12. Herborn CU, Lauenstein TC, Vogt FM, Lauffer RB, Debatin JF, and Ruehm SG (2002). Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. AJR Am J Roentgenol 179, 1567-1572.
13. Anzai Y and Prince MR (1997). Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 7, 75-81.
14. Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, and Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 96, 703-708.
15. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, and Josephson L (1990). Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175, 489-493.
16. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, and Weissleder R (2003). Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348, 2491-2499.
17. McCauley TR, Rifkin MD, and Ledet CA (2002). Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast. J Magn Reson Imaging 15, 492-497.
18. Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, and Brechbiel MW (2003). Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 50, 758-766.
19. Daldrup-Link HE and Brasch RC (2003). Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13, 354-365 Epub 2002 October 2031.
20. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, and Brasch RC (1987). Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 22, 665-671.
21. Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, and Brasch RC (1998). Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16, 225-230.
22. Marzola P, Farace P, Calderan L, Crescimanno C, Lunati E, Nicolato E, Benati D, Degrassi A, Terron A, Klapwijk J, Pesenti E, Sbarbati A, and Osculati F (2003). In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer 104, 462-468.
23. Wang Z, Su MY, Najafi A, and Nalcioglu O (2001). Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI. Magn Reson Imaging 19, 1063-1072.
24. Bhujwalla MZ, Artemov D, Natarajan K, Solaiyappan M, Kollars P, and Kristjansen PE (2003). Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res 9, 355-362.
25. Shames DM, Kuwatsuru R, Vexler V, Muhler A, and Brasch RC (1993). Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 29, 616-622.
26. van Dijke CF, Brasch RC, Roberts TP, Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P, and Schwickert HC (1996). Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198, 813-818.
27. Saeed M, van Dijke CF, Mann JS, Wendland MF, Rosenau W, Higgins CB, and Brasch RC (1998). Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging 8, 561-567.
28. Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, and Neeman M (2002). Overexpression of vascular endothelial growth factor 165 drives peri-tumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res 62, 6731-6739.
29. Dafni H, Landsman L, Schechter B, Kohen F, and Neeman M (2002). MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 15, 120-131.
30. Dafni H, Gilead A, Nevo N, Eilam R, Harmelin A, and Neeman M (2003). Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin. Magn Reson Med 50, 904-914.
31. Israely T, Dafni H, Granot D, Nevo N, Tsafriri A, and Neeman M (2003). Vascular remodeling and angiogenesis in ectopic ovarian transplants: a crucial role of pericytes and vascular smooth muscle cells in maintenance of ovarian grafts. Biol Reprod 68, 2055-2064 Epub 2003 January 2022.
32. Neeman M and Dafni H (2003). Structural, functional, and molecular MR imaging of the microvasculature. Annu Rev Biomed Eng 5, 29-56.
33. Ziv K, Nevo N, Dafni H, Israely T, Granot D, Brenner O, and Neeman M (2004). Longitudinal MRI tracking of the angiogenic response to hind limb ischemic injury in the mouse. Magn Reson Med 51, 304-311.
34. Goldshmidt O, Zcharia E, Aingorn H, Guatta-Rangini Z, Atzmon R, Michal I, Pecker I, Mitrani E, and Vlodavsky I (2001). Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J Biol Chem 276, 29178-29187.
35. Vlodavsky I (1999). Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cells. Current Protocols in Cell Biology, pp. 10.14.11-10.14.14 John Wiley & Sons Inc., Hoboken, NJ.
36. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, and Schirrmacher V (1983). Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 43, 2704-2711.
37. Witte MH, Way DL, Witte CL, and Bemas M (1997). Lymphangiogenesis: mechanisms, significance and clinical implications. In Goldberg, EM, Rosen, EM (Eds.), Regulation of Angiogenesis, Vol. 79, pp. 65-112 Birkhauser Verlag, Basel.
38. Boardman KC and Swartz MA (2003). Interstitial flow as a guide for lymphangiogenesis. Circ Res 92, 801-808.
39. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, and Dvorak HF (2002). Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196, 1497-1506.